171 related articles for article (PubMed ID: 14742186)
1. Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance.
Bantar C; Vesco E; Heft C; Salamone F; Krayeski M; Gomez H; Coassolo MA; Fiorillo A; Franco D; Arango C; Duret F; Oliva ME
Antimicrob Agents Chemother; 2004 Feb; 48(2):392-5. PubMed ID: 14742186
[TBL] [Abstract][Full Text] [Related]
2. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
3. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
Thauvin-Eliopoulos C; Tripodi MF; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 1997 May; 41(5):1053-7. PubMed ID: 9145868
[TBL] [Abstract][Full Text] [Related]
5. Reduction in multiresistant nosocomial infections in neonates following substitution of ceftazidime with piperacillin/tazobactam in empiric antibiotic therapy.
Flidel-Rimon O; Friedman S; Gradstein S; Bardenstein R; Shinwell ES
Acta Paediatr; 2003 Oct; 92(10):1205-7. PubMed ID: 14632339
[TBL] [Abstract][Full Text] [Related]
6. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
Lan CK; Hsueh PR; Wong WW; Fung CP; Lau YT; Yeung JY; Young GT; Su CC
J Microbiol Immunol Infect; 2003 Sep; 36(3):182-6. PubMed ID: 14582562
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species.
Schwaber MJ; Graham CS; Sands BE; Gold HS; Carmeli Y
Antimicrob Agents Chemother; 2003 Jun; 47(6):1882-6. PubMed ID: 12760862
[TBL] [Abstract][Full Text] [Related]
9. Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae.
Akhan S; Coskunkan F; Tansel O; Vahaboglu H
Scand J Infect Dis; 2001; 33(7):512-5. PubMed ID: 11515761
[TBL] [Abstract][Full Text] [Related]
10. The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates.
Lee J; Oh CE; Choi EH; Lee HJ
Int J Infect Dis; 2013 Aug; 17(8):e638-43. PubMed ID: 23523562
[TBL] [Abstract][Full Text] [Related]
11. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Altunsoy A; Aypak C; Azap A; Ergönül Ö; Balık I
Int J Med Sci; 2011; 8(4):339-44. PubMed ID: 21647326
[TBL] [Abstract][Full Text] [Related]
12. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.
Meyer E; Lapatschek M; Bechtold A; Schwarzkopf G; Gastmeier P; Schwab F
Intensive Care Med; 2009 May; 35(5):862-70. PubMed ID: 19034426
[TBL] [Abstract][Full Text] [Related]
13. Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Pillay T; Pillay DG; Adhikari M; Sturm AW
Am J Perinatol; 1998 Jan; 15(1):47-51. PubMed ID: 9475688
[TBL] [Abstract][Full Text] [Related]
14. Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
Plüss-Suard C; Pannatier A; Ruffieux C; Kronenberg A; Mühlemann K; Zanetti G
Antimicrob Agents Chemother; 2012 Feb; 56(2):989-94. PubMed ID: 22123703
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
[TBL] [Abstract][Full Text] [Related]
17. Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting.
Nadrah K; Pirs M; Kreft S; Mueller Premru M; Beovic B
J Chemother; 2018 May; 30(3):150-156. PubMed ID: 29431031
[TBL] [Abstract][Full Text] [Related]
18. Control of multi-resistant bacteria and ventilator-associated pneumonia: is it possible with changes in antibiotics?
Jukemura EM; Burattini MN; Pereira CA; Braga AL; Medeiros EA
Braz J Infect Dis; 2007 Aug; 11(4):418-22. PubMed ID: 17873997
[TBL] [Abstract][Full Text] [Related]
19. Temporal association between antibiotic use and resistance in
Ryu S; Klein EY; Chun BC
Antimicrob Resist Infect Control; 2018; 7():83. PubMed ID: 30026941
[TBL] [Abstract][Full Text] [Related]
20. Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem.
Raveh D; Muallem-Zilcha E; Greenberg A; Wiener-Well Y; Schlesinger Y; Yinnon AM
QJM; 2006 Jun; 99(6):397-406. PubMed ID: 16682440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
